To report the baseline results of a longitudinal psychosocial study that forms part of the IMPACT study, a multi-national investigation of targeted prostate cancer (PCa) screening among men with a known pathogenic germline mutation in the BRCA1 or BRCA2 genes.
Men enrolled in the IMPACT study were invited to complete a questionnaire at collaborating sites prior to each annual screening visit. The questionnaire included sociodemographics and the following measures: Hospital Anxiety and Depression Scale (HADS), Impact of Event Scale (IES), Short Form 36 (SF36), Memorial Anxiety Scale for PCa (MAX-PC), Cancer Worry Scale (CWS), risk perception and knowledge. The results of the baseline questionnaire are presented.
432 men completed questionnaires: 98 and 160 had mutations in BRCA1/BRCA2 genes, respectively, and 174 were controls (familial mutation negative). Participants' perception of PCa risk was influenced by genetic status. Knowledge levels were high and unrelated to genetic status. Mean scores for HADS and SF36 were within reported general population norms and mean IES scores were within normal range.IES mean intrusion and avoidance scores were significantly higher in BRCA1/2 carriers than controls and higher in men with increased PCa risk perception. At the multivariate level, risk perception contributed more significantly to variance in IES scores than genetic status.
This is the first study to report the psychosocial profile of men with BRCA1/2 mutations undergoing PCa screening. No clinically concerning levels of general or cancer-specific distress or poor quality of life were detected in the cohort as a whole. A small subset of participants reported higher levels of distress, suggesting the need for health care professionals offering PCa screening to identify these risk factors and offer additional information and support to men seeking PCa screening. This article is protected by copyright. All rights reserved.
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 March 2019.
All research outputs
#27,900,690
of 34,560,275 outputs
Outputs from British Journal of Urology
#7,336
of 8,066 outputs
Outputs of similar age
#289,976
of 374,077 outputs
Outputs of similar age from British Journal of Urology
#71
of 77 outputs
Altmetric has tracked 34,560,275 research outputs across all sources so far. This one is in the 16th percentile – i.e., 16% of other outputs scored the same or lower than it.
So far Altmetric has tracked 8,066 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.5. This one is in the 8th percentile – i.e., 8% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 374,077 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 18th percentile – i.e., 18% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 77 others from the same source and published within six weeks on either side of this one. This one is in the 6th percentile – i.e., 6% of its contemporaries scored the same or lower than it.
